These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3921593)

  • 1. Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
    Masala A; Alagna S; Rovasio PP; Deplano A; Anania V; Chiandussi L; Langer M
    J Endocrinol Invest; 1985 Feb; 8(1):25-9. PubMed ID: 3921593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prolactin secretion by nomifensine in man.
    Masala A; Alagna S; Devilla L; Delitala G; Rovasio PP
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):237-41. PubMed ID: 6771065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
    Bauer AG; Wilson JH; Lamberts SW; Blom W
    Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Contessini M; Bessarione D; Giordano G
    Neuroendocrinology; 1983 Dec; 37(6):406-10. PubMed ID: 6657002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Giordano G
    J Endocrinol Invest; 1983 Apr; 6(2):125-8. PubMed ID: 6408155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
    Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
    J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactin and estradiol levels in the plasma of patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; Zúñiga Pérez-Lemaur M; Valle Cagigas M; Leno Valencia L
    Rev Clin Esp; 1985 Jan; 176(1):13-7. PubMed ID: 2986206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolactin in females with liver cirrhosis].
    Grün R
    Z Gastroenterol; 1985 Aug; 23(8):446-54. PubMed ID: 3933200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood prolactin patterns in hepatic cirrhosis].
    Ardizzi A; Saglietti G; Grugni G; Morabito F
    Minerva Med; 1994 Oct; 85(10):511-3. PubMed ID: 7800192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
    Monza GC; Lampertico M; Locatelli S; Sali L; Cocchi D
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
    Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
    Moriondo P; Travaglini P; Nissim M; Faglia G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
    Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats.
    Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation on serum prolactin in hepatic cirrhosis.
    Mukherjee S; Kar M; Dutta S
    J Indian Med Assoc; 1991 Nov; 89(11):307-8. PubMed ID: 1787316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.